Guangzhou Pharma Absorbs Guangzhou Baiyunshan Pharma
publication date: Dec 3, 2012
In a reshuffling of assets, Guangzhou Pharma Holding is combining two of its companies. Guangzhou Pharma Co. (GPC) will acquire the assets of Guangzhou Baiyunshan Pharma. The surviving company, GPC, currently has a market capitalization of $2.2 billion. It is known mainly for its TCM products. Baiyunshan makes APIs for chemical drugs, especially antibiotics, and also produces TCM materials and finished TCM products. Its market capitalization is $1.2 billion. The share prices of both companies dropped 10% today after the purchase was given regulatory approval. More details....
Stock Symbols: (SHA: 600332) (SHE: 000522)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.